Speaking Engagement

Rare Disease Innovation and Partnering Summit

FDA Clinical Process and U.S. Regulatory Submissions

02 Dec 2020 02:30 p.m. - 03:15 p.m.


Informa Connect’s Rare Disease Summit convenes industry, patient groups, investors and policy makers to unite in areas of unmet medical need and create life-transforming therapies and breakthroughs. Connect with key stakeholders and propel curative progress, orphan product success and patient advocacy.

Bethany Hills was a speaker for the "FDA Clinical Process and U.S. Regulatory Submissions" session.

Additional speakers for the session:

Leonide Saad - CEO, Alkeus Pharmaceuticals, Inc.

Mark A. Rutter - Senior Director, Global Regulatory Policy, Biogen


Close
Feedback

Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.